Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical Pharmacology Study of E3810 Tablets in Healthy Adult Japanese Males
jRCT2080221249Phase 1
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of lucitanib in Peptic ulcer disease (PUD) (4 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Primary pharmacokinetic and safety endpoints.
02
Drugs
lucitanib
03
Conditions
Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on jRCT2080221249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221249.